What Happens to Claim Scope When “Comprise” and “Consists Of” Are Used Together in the Same Claim?
On January 7, 2020, in Amgen Inc. v. Amneal Pharmaceuticals, the CAFC decided that the open ended term “comprising” controlled,…
On January 7, 2020, in Amgen Inc. v. Amneal Pharmaceuticals, the CAFC decided that the open ended term “comprising” controlled,…
The holiday season is upon us! As our part of the hemisphere gets colder, we prepare ourselves for the festive…
The USPTO examiners use the broadest reasonable interpretation (BRI) when construing claims during examination of patent applications. The BRI standard…
Open Enrollment Choices? With open enrollment happening right now or very soon for most United States-based companies, it is worth…
The United States Court of Appeals for the Federal Circuit (“CAFC” or “Federal Circuit”) recently issued two precedential decisions on…
On October 31, 2019, the United States Patent and Trademark Office (“USPTO”) released the SUCCESS report, focusing on the participation…